Inhibikase Therapeutics Inc. (IKT) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-12-15
12:52 pm
Sale
2021-12-1413DInhibikase Therapeutics, Inc.
IKT
FiveT Investment Management Ltd208,333
4.970%
-35,786decrease
(-14.66%)
Filing
History
2021-06-21
12:01 pm
Purchase
2021-06-1613DInhibikase Therapeutics, Inc.
IKT
FiveT Investment Management Ltd244,119
5.830%
244,119increase
(New Position)
Filing
History
2021-03-23
1:32 pm
Purchase
2020-12-2213GInhibikase Therapeutics, Inc.
IKT
Kalman Daniel291,385
14.800%
291,385increase
(New Position)
Filing
History
2021-02-11
4:06 pm
Purchase
2020-12-2213GInhibikase Therapeutics, Inc.
IKT
Werner Milton H.906,937
53.100%
906,937increase
(New Position)
Filing
History
Goto Prev, 0, 1